Wire Stories
Dr. Reddy’s Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy�s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together...